To work collaboratively to:
- educate and raise awareness of the clinical benefits of proton therapy among patients, providers, clinicians, payers, policymakers, and other stakeholders,
- ensure patient choice and access to affordable proton therapy, and
- encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.
NAPT’s supporting members include 47 of the nation’s leading cancer centers, a number of whom are National Cancer Institute-designated comprehensive cancer centers and National Comprehensive Care Network (NCCN) members.